drugset / Trial / NCT05127525
EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-masked, multicenter, study to evaluate the efficacy, safety, and tolerability of IRX-101 versus 5% povidone-iodine (PI) in subjects receiving intravitreal anti-VEGF injections. The study will be conducted in up to 30 centers in the United States (US).
Timeline
- Start
- 2021-11-15
- Primary completion
- 2022-01-31
- Completion
- 2022-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IRX-101 | Unknown | — | Topical |
| Comparator | Povidone-Iodine | Other / unclassified | — | Topical |